Aurobindo Pharma Fundamental Analysis & Shareholding Pattern

Aurobindo Pharma NSE

473.25 00.00 (1.04%) Profit Profit

Pharmaceuticals

To view real-time data of Aurobindo Pharma and trade with industry first features, Login or Open Free Demat Account.

Showing Fundamental Analysis

Share Price

Technical Analysis

Fundamental Analysis

Financial Results

Stock Performance

Peer Comparision

Company Fundamentals

Company Valuation

Market Cap (Rs Cr.)	27,878.96
Book Value (Rs)	292.59
Face Value (Rs)	1.00

P/E ratio	19.09
Dividend Yield	1.89 %

Ownership & Shareholding

Company Ownership

Promoters

Non-Promoters

Government

Domestic Instituitional Investors

Foreign Instituitional Investors

Others

Shareholding Pattern

Held by	Dec-2022	Jun-2022	Mar-2022	Dec-2021	Sept-2021
Promoters	51.84 %	51.83 %	51.83 %	51.83 %	51.84 %
Non-Promoters	0.59 %	0.73 %	0.69 %	0.64 %	0.60 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Domestic Instituitions	14.89 %	17.30 %	17.48 %	16.49 %	15.52 %
Foreign Instituitions	22.80 %	21.18 %	21.27 %	21.83 %	22.14 %
Others	9.88 %	8.96 %	8.73 %	9.22 %	9.90 %

Sector

Sector	Pharmaceuticals
Sub Sector	Pharmaceuticals & Drugs
Company Classification	Largecap

Exchange Scrips

BSE	sec_id
NSE	sec_id
ISIN	INE406A01037

Stock Part of Following Indices

Name	Current Value	Change	Change %	Open	High	Low	Prev Close
MIDCAP	24,042.13	69.88	0.29%	24,203.32	24,262.76	24,057.63	24,042.13
BSE500	22,805.76	139.1	0.61%	22,952.70	23,015.91	22,801.22	22,805.76
BSE200	7,262.56	43.57	0.6%	7,312.29	7,329.97	7,258.14	7,262.56
MSL400	6,455.54	26.46	0.41%	6,484.60	6,511.44	6,462.56	6,455.54
BSE100	17,265.19	106.96	0.62%	17,381.49	17,422.25	17,247.99	17,265.19
CARBON	2,816.02	18.11	0.64%	2,835.08	2,841.98	2,811.77	2,816.02
BSE HC	21,623.97	-88.5	-0.41%	21,639.68	21,728.15	21,494.76	21,623.97
ALLCAP	6,549.14	40.31	0.62%	6,590.59	6,609.65	6,549.05	6,549.14
MID150	8,568.67	23.43	0.27%	8,610.05	8,640.35	8,565.79	8,568.67
NIFTY MID100 FREE	29,997.50	94.75	0.32%	30,204.35	30,284.60	29,983.10	29,997.50
NIFTY TOTAL MKT	7,979.40	50.45	0.63%	8,038.40	8,054.60	7,978.70	7,979.40
NIFTY MID LIQ 15	7,254.55	60.75	0.84%	7,320.20	7,345.30	7,266.00	7,254.55
MIDCPNIFTY	6,780.15	40.2	0.59%	6,840.25	6,852.30	6,780.75	6,780.15
NIFTY PHARMA	11,743.20	-67.05	-0.57%	11,790.80	11,806.15	11,635.65	11,743.20
NIFTY 500	14,330.35	90.5	0.63%	14,436.25	14,464.90	14,327.75	14,330.35
NIFTY 200	8,854.30	55.0	0.62%	8,921.15	8,938.55	8,849.65	8,854.30
NIFTYMCAP50	8,455.05	32.65	0.39%	8,519.60	8,535.80	8,445.60	8,455.05

Aurobindo Pharma Fundamental Analysis Overview

Aurobindo Pharma Fundamental Analysis offers an overview of the company's Market Capitalization, Book Value, P/E Ratio, Dividend Yield and more. It helps to analyse the company's fundamental position and its current shareholding pattern and historical shareholding movement. Presently, the current market cap of Aurobindo Pharma is Rs. 27,878.96. The Face Value and Book Value per share are Rs. 1.00 and Rs. 292.59 respectively. Current P/E ratio of Aurobindo Pharma stands at 19.09. The promoters holding in the company stands at , while Domestic Institutions stand at 00.00% and Foreign Institutions hold 00.00. While understanding and analysing Fundamentals of a company is very crucial, it is equally important to look at the Share Price, Stock Performance, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.